Treatment of Mycobacterium ulcerans infection by hyperbaric oxygenation | Canada Hyperbarics Skip to main content
Study Aviat Space Environ Med 1975

Treatment of Mycobacterium ulcerans infection by hyperbaric oxygenation

Krieg R, Wolcott J, Confer A — Aviat Space Environ Med, 1975

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated whether hyperbaric oxygen therapy could treat Mycobacterium ulcerans infections in mice, comparing three different daily treatment protocols to an untreated control group.

What They Found

The most effective protocol involved 100% oxygen at 2.5 ATA for 1.25 hours, twice a day. After 25 weeks, this treatment group had only 2 autoamputated feet and 12 deaths among the mice, compared to 18 amputated feet and 24 deaths in the control group. This indicates that hyperbaric oxygenation had a beneficial effect in mice infected with M. ulcerans.

Canadian Relevance

No direct Canadian connection identified. The study was not conducted in Canada, did not involve Canadian authors, and Mycobacterium ulcerans infection is not a Health Canada-recognised indication for HBOT.

Study Limitations

This study was conducted on mice, meaning its findings may not directly translate to human patients.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Wound Care
Source Pubmed
PubMed ID 1180783
Year Published 1975
Journal Aviat Space Environ Med
MeSH Terms Animals; Humans; Hyperbaric Oxygenation; Mice; Mice, Inbred Strains; Mycobacterium Infections; Skin Diseases, Infectious; Skin Ulcer

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology